1366664-52-9

Basic information

• Product Name: (R)-3-Phenoxy-pyrrolidine.HCl
• Synonyms: (R)-3-Phenoxy-pyrrolidine.HCl;(3R)-3-phenoxypyrrolidine hydrochloride
• CAS NO: 1366664-52-9
• Molecular Formula: C10H14ClNO
• Molecular Weight: 199.67726
• Mol File: 1366664-52-9.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: (R)-3-Phenoxy-pyrrolidine.HCl(CAS DataBase Reference)
• NIST Chemistry Reference: (R)-3-Phenoxy-pyrrolidine.HCl(1366664-52-9)
• EPA Substance Registry System: (R)-3-Phenoxy-pyrrolidine.HCl(1366664-52-9)

Safety Data

• Hazardous Substances Data: 1366664-52-9(Hazardous Substances Data)

Usage

General Description

(R)-3-Phenoxy-pyrrolidine.HCl is a chemical compound that consists of a pyrrolidine ring with a phenoxy group attached to it. The HCl indicates that it is in the form of a hydrochloride salt. (R)-3-Phenoxy-pyrrolidine.HCl has potential applications in pharmaceuticals, agrochemicals, and other industries due to its unique structure and properties. It may have a role as an anti-inflammatory agent, an antineoplastic agent, and an antithrombotic agent. Further research is being conducted to explore its potential uses and benefits.

Upstream product

• 83220-74-0 tert-butyl 3-phenoxypyrrolidine-1-carboxylate 
• 108-95-2 phenol 
• 931409-70-0 (S)-tert-butyl 3-phenoxypyrrolidine-1-carboxylate 

Relevant articles and documents

SUBSTITUTED 2, 4-DIAMINO-QUINOLINE DERIVATIVES FOR USE IN THE TREATMENT OF PROLIFERATIVE DISEASES

This application discloses compounds according to generic Formula (I): wherein all variables are defined as described herein which exhibit strong inhibition effects on various cancer cell lines. The compounds disclosed herein are useful for the treatment of proliferative diseases, including neoplastic diseases such as cancer and non- neoplastic disorders such as rheumatoid arthritis. Also disclosed are pharmaceutical compositions containing compounds of Formula (I) and at least one carrier, diluent or excipient and optionally one or more additional therapeutically active agents, including anticancer agents. This application also discloses methods for treating a proliferative disease, including neoplastic diseases such as cancer and non- neoplastic disorders such as rheumatoid arthritis.

CARBOXAMIDE DERIVATIVES AS MUSCARINIC RECEPTOR ANTAGONISTS

The invention relates to compounds of Formula (I) processes and intermediates for their preparation, their use as muscarinic antagonists and pharmaceutical composition containing them.